Cas no 1125-02-6 (N-(1-Cyanocyclohexyl)formamide)
N-(1-Cyanocyclohexyl)formamide Chemical and Physical Properties
Names and Identifiers
-
- N-(1-Cyanocyclohexyl)formamide
- DTXSID00446707
- 1125-02-6
- AKOS006324142
- MFCD11499347
- SCHEMBL10907172
-
- MDL: MFCD11499347
- Inchi: 1S/C8H12N2O/c9-6-8(10-7-11)4-2-1-3-5-8/h7H,1-5H2,(H,10,11)
- InChI Key: URXDVBRMOBTTLS-UHFFFAOYSA-N
- SMILES: O=CNC1(C#N)CCCCC1
Computed Properties
- Exact Mass: 152.094963011g/mol
- Monoisotopic Mass: 152.094963011g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- Complexity: 186
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 52.9?2
Experimental Properties
- Density: 1.1±0.1 g/cm3
- Boiling Point: 368.4±21.0 °C at 760 mmHg
- Flash Point: 176.6±22.1 °C
- Vapor Pressure: 0.0±0.8 mmHg at 25°C
N-(1-Cyanocyclohexyl)formamide Security Information
- Signal Word:warning
- Hazard Statement: H303+H313+H333
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
N-(1-Cyanocyclohexyl)formamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 080143-1g |
N-(1-Cyanocyclohexyl)formamide |
1125-02-6 | 1g |
£226.00 | 2022-03-01 | ||
| Fluorochem | 080143-2g |
N-(1-Cyanocyclohexyl)formamide |
1125-02-6 | 2g |
£372.00 | 2022-03-01 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1766124-1g |
N-(1-Cyanocyclohexyl)formamide |
1125-02-6 | 98% | 1g |
¥9809.00 | 2024-08-09 |
N-(1-Cyanocyclohexyl)formamide Related Literature
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
Additional information on N-(1-Cyanocyclohexyl)formamide
Comprehensive Guide to N-(1-Cyanocyclohexyl)formamide (CAS No. 1125-02-6): Properties, Applications, and Market Insights
N-(1-Cyanocyclohexyl)formamide (CAS No. 1125-02-6) is a specialized organic compound that has garnered significant attention in pharmaceutical and agrochemical research. This cyanocyclohexyl derivative is characterized by its unique molecular structure, combining a formamide group with a cyanocyclohexyl moiety, making it a valuable intermediate in synthetic chemistry. Researchers and industry professionals frequently search for "N-(1-Cyanocyclohexyl)formamide uses" and "CAS 1125-02-6 applications," reflecting its growing importance in various scientific fields.
The compound's molecular formula, C8H12N2O, gives it distinct chemical properties that are exploited in multiple applications. With a molecular weight of 152.20 g/mol, N-(1-Cyanocyclohexyl)formamide exhibits moderate solubility in polar organic solvents, which is crucial for its use in laboratory synthesis. Recent trends show increased interest in "sustainable chemical intermediates" and "green synthesis routes for N-(1-Cyanocyclohexyl)formamide," aligning with the global push towards environmentally friendly chemical processes.
In pharmaceutical research, N-(1-Cyanocyclohexyl)formamide serves as a key building block for the development of novel drug candidates. Its structural features make it particularly valuable in creating central nervous system (CNS) active compounds, with researchers exploring its potential in addressing neurological disorders. The rise in searches for "neuroprotective agent synthesis" and "CNS drug intermediates" underscores the relevance of this compound in modern medicinal chemistry.
The agrochemical industry has also recognized the potential of CAS 1125-02-6, particularly in the development of new generation pesticides. Its cyanocyclohexyl structure contributes to the biological activity of certain crop protection agents, making it a subject of interest for researchers working on "next-generation agrochemicals" and "environmentally friendly pesticides." This aligns with current market demands for sustainable agricultural solutions.
From a synthetic chemistry perspective, N-(1-Cyanocyclohexyl)formamide offers several advantages. Its formamide group provides a reactive site for various transformations, while the cyanocyclohexyl moiety contributes to the stereochemical diversity of resulting compounds. Recent publications have highlighted its use in "asymmetric synthesis" and "chiral auxiliary applications," topics that are currently trending in organic chemistry forums and academic searches.
The global market for N-(1-Cyanocyclohexyl)formamide has shown steady growth, driven by increasing demand from both pharmaceutical and agrochemical sectors. Market analysts note particular interest in "high-purity CAS 1125-02-6" and "custom synthesis of cyanocyclohexyl derivatives," reflecting the compound's expanding applications. Quality specifications typically require purity levels above 98%, with strict control over impurities that might affect downstream applications.
Storage and handling of N-(1-Cyanocyclohexyl)formamide require standard laboratory precautions. The compound should be kept in tightly sealed containers under inert atmosphere when long-term storage is anticipated. These practical considerations are frequently searched alongside terms like "stability of formamide derivatives" and "handling cyanocyclohexyl compounds," indicating the practical concerns of researchers working with this material.
Recent advancements in analytical techniques have improved the characterization of N-(1-Cyanocyclohexyl)formamide. Modern methods such as HPLC-MS and NMR spectroscopy provide detailed information about its purity and structural features. These analytical aspects are increasingly important, as evidenced by search trends for "analytical methods for cyanocyclohexyl compounds" and "quality control of CAS 1125-02-6."
The future outlook for N-(1-Cyanocyclohexyl)formamide appears promising, with ongoing research exploring new applications in material science and specialty chemicals. Its unique structural features continue to attract attention from researchers investigating "advanced organic materials" and "functional chemical intermediates." As synthetic methodologies evolve, the compound's versatility is expected to lead to novel applications across multiple scientific disciplines.
For researchers considering working with CAS 1125-02-6, it's important to consult recent literature on its synthetic applications and safety profile. The compound's growing importance is reflected in the increasing number of publications and patents referencing N-(1-Cyanocyclohexyl)formamide, particularly in contexts related to "innovative chemical synthesis" and "specialty chemical development."
1125-02-6 (N-(1-Cyanocyclohexyl)formamide) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)